Metric Analysis: Telomir Pharmaceuticals Inc (TELO)’s Key Ratios in the Limelight

For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.

In the latest session, Telomir Pharmaceuticals Inc (NASDAQ: TELO) closed at $2.01 down -4.74% from its previous closing price of $2.11. In other words, the price has decreased by -$4.74 from its previous closing price. On the day, 1.56 million shares were traded.

Ratios:

For a deeper understanding of Telomir Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.75 and its Current Ratio is at 0.75.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on February 21, 2025, initiated with a Buy rating and assigned the stock a target price of $15.

Stock Price History:

Over the past 52 weeks, TELO has reached a high of $8.40, while it has fallen to a 52-week low of $1.88. The 50-Day Moving Average of the stock is -22.35%, while the 200-Day Moving Average is calculated to be -52.92%.

Shares Statistics:

A total of 29.76M shares are outstanding, with a floating share count of 17.25M. Insiders hold about 42.03% of the company’s shares, while institutions hold 12.39% stake in the company.

Leave a Reply

Your email address will not be published. Required fields are marked *

DWinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.